Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-27T00:23:03.826Z Has data issue: false hasContentIssue false

Case 2 - The woman who couldn’t handle her lips smacking any longer

Published online by Cambridge University Press:  19 October 2021

Takesha Cooper
Affiliation:
University of California, Riverside
Gerald Maguire
Affiliation:
University of California, Riverside
Stephen Stahl
Affiliation:
University of California, San Diego
Get access

Summary

Pretest self-assessment question (answer at the end of the case)

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cornett, EM, Novitch, M, Kaye, AD, et al. Medication-induced tardive dyskinesia: a review and update. Ochsner J 2017; 17: 162–74.Google ScholarPubMed
Kang, NR, Kim, MD. Tardive dyskinesia: treatment with aripiprazole. Clin Psychopharmacol Neurosci 2011; 9:18. https://doi.org/10.9758/cpn.2011.9.1.1Google Scholar
Kim, SW, Lee, SY, Kim, JM, et al.Resolution of tardive dyskinesia following a switch from long-acting injectable risperidone to aripiprazole. Clin Psychopharmacol Neurosci 2008; 6:75–8.Google Scholar
Stahl, SM. Antipsychotic agents. In: Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 5th edn. New York, NY: Cambridge University Press, 2013; pp. 133–53.Google Scholar
Stahl, SM. Neuronal traffic signals in tardive dyskinesia: not enough “stop” in the motor striatum. CNS Spectr 2017; 22: 427–34. https://doi.org/10.1017/s109285291700061xCrossRefGoogle ScholarPubMed
Stahl, SM. (2018). Comparing pharmacologic mechanism of action for the vesicular monoamine transporter 2 (VMAT2) inhibitors valbenazine and deutetrabenazine in treating tardive dyskinesia: does one have advantages over the other? CNS Spectr, 23: 239–47. https://doi.org/10.1017/s1092852918001219CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×